There is a critical need for safe and effective solutions to acute and chronic pain management in both the in-patient and outpatient settings. This panel will explore the evolving landscape of non-opioid/opioid sparing pain management, including recently approved therapies and emerging device innovations poised to transform the market and alter treatment paradigms for both neuropathic and nociceptive pain. Attendees will gain insight into the clinical need, the biologic pathways and the market potential driving the future of pain management beyond opioids.